ACIP Presentation Slides: February 22-24, 2023 Meeting
Note: These files are not yet 508
Slides will be added as they become available.
February 22, 2023
Welcome & Introductions
- Introduction
Dr. G Lee
Dr. M Wharton
Mpox Vaccine
- Introduction [16 pages]
Dr. Pablo Sanchez - Epidemiology of mpox during 2022 outbreak in the United States [18 pages]
Dr. Sascha Ellington - JYNNEOS Vaccine Safety [26 pages]
Dr. Jonathan Duffy - JYNNEOS Vaccine Effectiveness [21 pages]
Dr. Anna Chard - Mpox vaccine acceptability and uptake from cross-sectional surveys [26 pages]
Dr. Kevin P. Delaney - Interim Clinical Considerations [12 pages]
Dr. Rosalind Carter - EtR: Use of JYNNEOS during mpox outbreaks [48 pages]
Dr. Agam Rao
Respiratory disease surge, Fall 2022, United States
- Dr. José R. Romero
Influenza Vaccine
- Introduction [3 pages]
Dr. Keipp Talbot - U.S. Influenza activity update [7 pages]
Dr. Lisa Grohskopf - Preliminary 2022-23 influenza vaccine effectiveness: CDC networks [25 pages]
Ms. Samantha Olson, Dr. Nathaniel Lewis, Dr. Mark Tenforde - Preliminary 2022-23 influenza vaccine effectiveness: Wisconsin [15 pages]
Dr. Huong McClean - Published Estimates of LAIV Effectiveness [4 pages]
Dr. Lisa Grohskopf
Pneumococcal Vaccines
- Introduction [9 pages]
Dr. Katherine Poehling - Epidemiology of pneumococcal disease among U.S. children [21 pages]
Mr. Ryan Gierke - Estimating the impact of higher-valency PCVs on pediatric outpatient ARI visits and antibiotic use [27 pages]
Ms. Laura King - PCV20 Phase 2/3 study results among children [18 pages]
Dr. Wendy Watson - Preliminary EtR (incl. GRADE) for PCV20 use in U.S. children [57 pages]
Dr. Miwako Kobayashi - Workgroup considerations [12 pages]
Dr. Miwako Kobayashi
February 23, 2023
Welcome & Introductions
- Introduction
Dr. G Lee
Dr. M Wharton
Agency Updates
Meningococcal Vaccines
- Introduction [8 pages]
Dr. Kathy Poehling
- Epidemiology of meningococcal disease in the United States [17 pages]
Ms. Amy Rubis - Pfizer pentavalent meningococcal vaccine [26 pages]
Dr. Jason Maguire - Workgroup considerations [15 pages]
Dr. Sam Crowe
Polio Vaccine
- Introduction [2 pages]
Dr. Oliver Brooks - Recommendations for Adult Polio Vaccination [29 pages]
Dr. Sarah Kidd
RSV Vaccines – Pediatric/Maternal
- Introduction [5 pages]
Dr. S Long - Cost effectiveness analysis for nirsevimab – CDC model [51 pages]
Dr. David Hutton - Cost effectiveness analysis for nirsevimab – Comparison to manufacturer model [25 pages]
Dr. Ismael Ortega Sanchez - Evidence to Recommendations framework for nirsevimab [92 pages]
Dr. Jefferson Jones - Clinical considerations for nirsevimab [16 pages]
Dr. Jefferson Jones - Safety and Efficacy of RSV Bivalent PreF Maternal Vaccine [31 pages]
Dr. Iona Munjal - Workgroup considerations [6 pages]
Dr. Katherine Fleming-Dutra
RSV Vaccines – Adult
- Introduction [8 pages]
Dr. Camille Kotton - Cost effectiveness of the GSK and Pfizer vaccines (main CDC model) [37 pages]
Dr. David Hutton - Comparison of cost effectiveness results of the main CDC model and each manufacturer model (GSK & Pfizer) [24 pages]
Dr. Ismael Ortega Sanchez - EtR (incl. GRADE) for 2 vaccines (GSK & Pfizer) [90 pages]
Dr. Michael Melgar - Vaccine policy questions (GSK & Pfizer) [2 pages]
Dr. Michael Melgar
Chikungunya Vaccine
- Introduction [7 pages]
Dr. Beth Bell - Global epidemiology of chikungunya [12 pages]
Dr. Susan Hills - Chikungunya in U.S. travelers [15 pages]
Ms. Nicole Lindsey - Persistent arthralgia following chikungunya [21 pages]
Ms. Nicole Lindsey - Workgroup considerations [4 pages]
Ms. Nicole Lindsey
Dengue Vaccines
- Introduction [8 pages]
Dr. W Chen - Takeda dengue vaccine (TAK-003) safety and efficacy [26 pages]
Dr. Shibidas Biswal - Workgroup considerations [22 pages]
Dr. Gabriela Paz-Bailey
Varicella
- Public health impact of 25 years of varicella vaccination in the United States [23 pages]
Dr. Mona Marin
February 24, 2023
Welcome & Introductions
- Introduction
Dr. G Lee
Dr. M Wharton
COVID-19 Vaccines
- Introduction [7 pages]
Dr. Matthew Daley - COVID-19 vaccine safety updates: CDC [43 pages]
Dr. Tom Shimabukuro - COVID-19 vaccine safety updates: FDA [17 pages]
Dr. Richard Forshee - VaST summary [10 pages]
Dr. Keipp Talbot - WG interpretation and summary [19 pages]
Dr. Evelyn Twentyman - Updates on COVID-19 hospitalizations: COVID-NET [14 pages]
Dr. Chris Taylor - Updates to COVID-19 vaccine effectiveness in the United States [29 pages]
Dr. Amadea Britton - Considerations for transitioning to bivalent primary series [32 pages]
Dr. Sara Oliver - Benefit/risk for COVID-19 vaccines [21 pages]
Dr. Megan Wallace - COVID-19 vaccines: future directions [37 pages]
Dr. Sara Oliver